top of page

Search Results

Results found for "InterAx Biotech"

  • đź“° GPCR Weekly News, March 27 to April 4, 2023

    Itch receptor MRGPRX4 interacts with the receptor activity-modifying proteins (RAMPs). Dopamine Receptor D1R and D3R and GRK4 Interaction in Hypertension. Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech Expansion of precision oncology pipeline announced by Exscientia Upcoming start-up ecosystem - leadXpro and InterAx (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

  • Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to...

    A Gαs preferentially interacts with dimeric β2-AR, but not monomeric β2-AR, in a resting state, resulting

  • SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

    immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies #drugdiscovery #biotechnology #research #ionchannels #biologics #biotech #pharma #pharmaindustry #pharmaceuticals #oncology #healthcare

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    In this podcast, he lays out the mindset that helped shape products used across biotech and academia—and That opened the door to something rare in functional pharmacology: plate-based GPCR internalization tracking The Endogenous Receptor “Aha” Eric’s second “aha” moment with pHSense came the day his team showed internalization their native, unmodified state—unlocking new questions about constitutive activity, agonist-induced internalization teaming, testing, and failing smarter. 🚀 Why This Matters: Whether you’re launching a tool, starting a biotech

  • GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth

    examine what happens when GPCR selectivity is encoded not at the receptor, but at the receptor–transducer interface SBI-553 at NTSR1 and PCO371 at PTH1R illustrate how intracellular modulators engage cytoplasmic interfaces Structural Biology and Drug Discovery at GPCRs Cryo-EM has transformed how we visualize receptor–ligand interactions One small molecule studied in the Manglik lab interacts with both the μ- and κ-opioid receptors, acting

  • The Truth About GPCR Product Launches: Years in the Making

    If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable failed in plate readers—too noisy, too dim. pHSense rewrote that rule, enabling high-throughput GPCR internalization Internalization as a Functional Readout The insight? GPCR internalization isn’t just a trafficking readout—it’s pharmacology. moment came when they ran a dose-response with Exendin-4 on GLP-1 receptors—and saw clean, plate-based internalization

  • Innovative Data-Driven Solutions: The pHSense Revolution

    Eric Trinquet, that moment arrived when his team successfully tracked GPCR internalization in native What if you could directly measure receptor internalization in physiologically relevant cells without These probes become brighter and have a longer lifespan as internalized receptors enter acidic endosomes—translating presented a data set that transformed everything: a clean, dose-dependent response of GLP-1 receptor internalization For the first time, a team demonstrated high-throughput internalization data in physiologically relevant

  • GPCR Happy Hour – Boston, Sept 2025

    When the biotech world gathers in Boston, this is where the real conversations begin. Every September, Boston welcomes the global biotech and drug discovery community. Why It Matters Connect with peers across biotech, CROs, and investment who are driving discovery forward Meet both the global biotech community and Boston’s local innovators in one room Be part of Dr. Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma

  • Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism

    In practice, these criteria test the purity of interaction.

  • A cryptic mode of GPCR regulation revealed

    activation of the β2-adrenoceptor (β2AR) causes its S-nitrosylation that is required for the receptor to internalize

  • GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions

    Corner delivers this week: high-impact insight into GPCR allostery, crafted for pharmacologists and biotech nuance into better decision-making. 🔍 This Week in Premium: Sneak Peek Industry insights:  Strategic biotech What you’ll learn: Reveal cryptic binding sites and time-dependent interactions.   This is where funders, peers, and biotech scouts are watching. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

  • N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling

    October 2022 "Neisseria meningitidis is a Gram-negative opportunistic pathogen that is responsible for causing human diseases with high mortality, such as septicemia and meningitis. The molecular mechanisms N. meningitidis employ to manipulate the immune system, translocate the mucosal and blood-brain barriers, and exert virulence are largely unknown. Human-associated bacteria encode a variety of bioactive small molecules with growing evidence for N-acyl amides as being important signaling molecules. However, only a small fraction of these metabolites has been identified from the human microbiota thus far. Here, we heterologously expressed an N-acyltransferase encoded in the obligate human pathogen N. meningitidis and identified 30 N-acyl amides with representative members serving as agonists of the G-protein coupled receptor (GPCR) S1PR4. During this process, we also characterized two mammalian N-acyl amides derived from the bovine medium. Both groups of metabolites suppress anti-inflammatory interleukin-10 signaling in human macrophage cell types, but they also suppress the pro-inflammatory interleukin-17A+ population in TH 17-differentiated CD4+ T cells." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2

    We have previously shown interaction between PKR2 and anosmin 1 in vitro.

  • C5aR2 receptor: The genomic twin of the flamboyant C5aR1

    C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 In addition, the structure of C5aR2 and its interaction specificity toward C5a is not structurally elucidated dynamics data presented in the current study are expected to further enrich the understanding of C5a-C5aR2 interaction

  • From GPCR Data Chaos to Decisive Action

    I call it the Lego Bucket Problem : You’ve got CRO output, internal assay data, maybe even some promising Hidden Cost of Good Science Without Systems I’ve seen this pattern again and again—across academia, biotech This is embedded consulting for biotech and VC teams who need to move fast —without compromising scientific Who I Work With ✅ Biotech Teams  – Especially those lacking in-house GPCR leads or overwhelmed by CRO assets in their portfolio. ✅ Contract Research Organizations (CROs)  – Wanting to better align with biotech

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    Kotliar share how three decades of curiosity evolved into a tech-powered platform for mapping GPCR-RAMP interactions Explore this week’s research, tools, and biotech insights in one place.

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    Plus: top tracks to watch at GPCR Forum 2025, fresh postdoc openings at the ADME/signaling interface Mastering inhibition isn’t just about avoiding drug–drug interactions. Kenakin Trusted insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost = embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped tools now used across biotech GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • GPCR Collaboration: From Models to Medicine

    Beyond Academia: Advising Biotech Carlsson’s collaborative philosophy has also found a place in the biotech It also allows Carlsson to stay plugged into the fast-changing needs of biotech while keeping his academic Whether in academia or biotech, the future belongs to research groups that can orchestrate ecosystems And for the next generation of researchers and biotech leaders, that is the real collaboration advantage

  • Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks

    GPCR tools and key moves in the biotech world. Dr. Explore this week’s research, tools, and biotech insights in one place.

  • Mapping Motion: Intermediate States, Deorphanization & Discovery

    Meanwhile, the industry is moving fast with AI-powered platforms, bold leadership moves, and strategic biotech Explore this week’s research, tools, and biotech insights in one place.

  • Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools

    “These tools can dramatically improve how scientists measure ligand-receptor interactions, visualize About Celtarys Research Celtarys Research is a biotech company based in Spain that specializes in the

  • Immunomodulatory Role of Neuropeptides in the Cornea

    with its dense sensory innervation and resident leukocyte populations make it an ideal tissue to study interactions of neuropeptide signaling and how it contributes to pathophysiology, which is likely due to complex interactions

  • GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors

    Discovery at Discovery on Target 2025 — The Track You Can’t Miss If you work in drug discovery  or biotech Over the years, we’ve built a global network of researchers, biotech leaders, and pharma innovators who together. 🚨 Mark your calendar for the GPCR Happy Hour Join us at GPCR Happy Hour , where scientists, biotech

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    Ajay Yekkirala shares the journey from academic pharmacologist to biotech entrepreneur—bridging curiosity When the global biotech crowd lands in Boston for Discovery on Target. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon

    Tools The Story Behind Celtarys – From Chemistry to Company   How does a medicinal chemist become a biotech Explore this week’s research, tools, and biotech insights in one place.

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Foundry: Science Meets Execution The Foundry is where we bring together biotech innovators, Venture , he shares decades of expertise in an accessible, on-demand format for scientists across academia, biotech

  • Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...

    reveals that both conventional and novel protein kinase C isozymes are involved in mGlu5a receptor internalization "The internalization of G protein-coupled receptors (GPCRs) can be regulated by PKC. isozymes (ΔcPKC and ΔnPKC) and employ these to investigate the contribution of PKC isozymes in the internalization Nonetheless, we determined that mGlu5a internalization was not altered upon the loss of cPKCs or nPKCs motif, we demonstrate that internalization of rat mGlu5a is mediated by Gαq/11 proteins (77% of the

  • đź“° GPCR Weekly News, March 20 to 26, 2023

    receptor against polycystic kidney disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

  • GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event

    Who should come This evening is open to pharma, biotech, academia, and students. This event is open to pharma, biotech, academia, and students.

  • Dr. GPCR Updates

    Dive into this week’s research, tools, and biotech updates all in one place.

bottom of page